Award
National Cancer Institute 5R01CA285620-03
Development of novel AAV vaccine strategy in a pre-clinical model of oral melanoma
Recipient
University of Minnesota
Award Amount
$485,977.00
Ceiling
$485,977.00
Awarded
December 11, 2025
Identifier
5R01CA285620-03
NIH grant awarded to develop AAV vaccine strategies for oral melanoma in a pre-clinical model, focusing on cancer immunotherapy and vaccine dosing.
Description
This NIH grant supports research on developing AAV vectors for cancer immunotherapy, specifically targeting oral melanoma in a pre-clinical dog model. The project aims to produce high titers of therapeutic vaccines and determine optimal dosing strategies.